MMSI
MERIT MEDICAL SYSTEMS INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 24 ▲ Merit Medical reported strong fourth quarter and full year 2025 resu…
- Apr 16 ▲ The U.S. Court of Appeals for the Federal Circuit dismissed an appea…
- Apr 30 ▲ Merit Medical reported Q1 2026 EPS of $0.94 (non-GAAP, the Street co…
- May 5 to May 11 ▲ 4 days of insider buys: $573.3K by 5 insiders, avg $61.14
- May 5 ▲ Four top executives at Merit Medical Systems, including the CEO, CFO…
- May 7 ▼ 1 insider sell $313.0K at $62.61
- Aug 4 ▼ 1 insider sell $1.8M at $85.00
- Aug 24 ▼ 1 insider sell $678.4K at $90.45
- Sep 30 ▲ 4 funds open new positions (13F)
- Oct 27 Freedom Capital Markets initiates
- Oct 29 ▲ Merit Medical reported Q3 2026 revenue of $416.2M (up 8.4% YoY) and…
- Nov 5 FDA: Merit Medical Presents Real-World Data from the AVF Cohort…
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders bought $573.3K at an average $61.14. 2 insiders sold $2.8M. Price is 41% above their cost.
- InstitutionsMIXED
Q3 2026: 38 added (4 new), 27 trimmed or exited. Largest new: Loomis Sayles & L P $18.8M, Boston Partners $18.5M.
- AnalystsBULLISH
14 of 18 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest +5.3% to 4.00M shares. 5.1 days to cover, ≈6.7% of shares.
- TrendDOWNTREND
2% below its 50-day average.
Who's buying
13F· Q3 2026| Fund | Move | Value |
|---|---|---|
| FULLER & THALER ASSET MANAGEMENT, INC. | ADD | $185.8M |
| FMR LLC | ADD | $124.6M |
| Neuberger Berman Group LLC | ADD | $117.7M |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | ADD | $91.4M |
| JPMORGAN CHASE & CO | ADD | $74.3M |
| Nuveen, LLC | ADD | $69.9M |
| UBS Group AG | ADD | $61.3M |
| VOYA INVESTMENT MANAGEMENT LLC | DOUBLED | $28.6M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
18 analystsPrice is below the lowest target. Median implies +24%.Targets as of Nov 17, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 12, 2026 | Freedom Capital Markets MAINTAIN | Hold |
| Oct 30, 2026 | Canaccord Genuity MAINTAIN | Buy |
| Oct 30, 2026 | JP Morgan MAINTAIN | Overweight |
| Oct 30, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 30, 2026 | Needham MAINTAIN | Buy |
| Oct 30, 2026 | BTIG MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Lewis Sheri EVP of Global Operations Sep 4, 2026 | AWARD | 8,371 sh |
Voigt Michel J. CHIEF HUMAN RESOURCES OFFICER Aug 24, 2026 | GIFT | 650 sh |
Peterson Neil W. CHIEF OPERATING OFFICER Aug 24, 2026 | SELL | $678.4K |
Peterson Neil W. CHIEF OPERATING OFFICER Aug 4, 2026 | SELL | $1.8M |
Voigt Michel J. CHIEF HUMAN RESOURCES OFFICER Jun 15, 2026 | GIFT | 65 sh |
Lloyd Brian G. CHIEF LEGAL OFFICER, SECRETARY Jun 5, 2026 | GIFT | 2,000 sh |
Gunderson Thomas J. Director May 20, 2026 | EXERCISE | $717.3K |
Gunderson Thomas J. Director May 20, 2026 | EXERCISE | $391.3K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
10 filings · 2 press releases · 6 bullish · 0 bearish · 1 mixed · 3 neutral- NEUTRAL PRESS RELEASENov 5, 2026
Merit Medical announced positive 6-month real-world patency results from the AVF cohort of the…
Monitor upcoming WRAP North America registry results and quarterly revenue disclosures for WRAPSODY sales traction. The positive real-world data may support gradual market share gains in dialysis…
- BULLISH 8-KOct 29, 2026
Merit Medical reported Q3 2026 revenue of $416.2M (up 8.4% YoY) and GAAP EPS of $0.70 (up 51%…
The raised guidance midpoint implies Q4 2026 non-GAAP EPS of ~$1.08-$1.12, suggesting continued momentum. The Solo Pace acquisition is small (~0.8% of market cap) but strategically expands the…
- BULLISH PRESS-RELEASEOct 29, 2026
Merit Medical reported Q3 2026 revenue of $416.2M (up 8.4% YoY) and non-GAAP EPS of $1.12 (up 22%…
The raised guidance for both revenue and non-GAAP EPS signals management confidence in continued momentum. Monitor Q4 2026 results for execution against the raised targets and any updates on the…
- NEUTRAL PRESS RELEASEOct 29, 2026
Merit Medical Systems acquired all remaining equity of Solo Pace for approximately $45 million…
The acquisition is small relative to Merit's $5.6B market cap and is not expected to materially affect near-term financials. Monitor future quarters for revenue contribution from Solo Pace products…
All MMSI filing & press-release reports (12)
- PRESS-RELEASE reportNov 5, 2026
- 8-K reportOct 29, 2026
- PRESS-RELEASE reportOct 29, 2026
- PRESS-RELEASE reportOct 29, 2026
- INST-CLUSTER reportOct 27, 2026
- PRESS-RELEASE reportJul 2, 2026
- CLUSTER reportMay 5, 2026
- CLUSTER reportMay 5, 2026
- PRESS-RELEASE reportApr 30, 2026
- COURT-RULING reportApr 16, 2026
- 8-K reportApr 13, 2026
- 8-K, 8-K reportFeb 24, 2026